Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Jordan J Karlitz"'
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-6 (2024)
Abstract US Preventive Services Task Force (USPSTF) guidelines recommend single-cancer screening for select cancers (e.g., breast, cervical, colorectal, lung). Advances in genome sequencing and machine learning have facilitated the development of blo
Externí odkaz:
https://doaj.org/article/038d720dd58e4957ae8482cf13d5bc6b
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:262-274
The incidence of early-onset colorectal cnacer-ie, colorectal cancer diagnosed in patients under the age of 50 years- has been increasing around the world. This Series paper provides a comprehensive review on the topic of early-onset colorectal cance
Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States
Autor:
Eric M. Montminy, Meijiao Zhou, Lauren Maniscalco, Rajiv Heda, Michelle Kang Kim, Swati G. Patel, Xiao-Cheng Wu, Steven H. Itzkowitz, Jordan J. Karlitz
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:334-341
Background: Carcinoids, frequently classified as “colorectal cancer” contribute to rising early-onset colorectal cancer (EOCRC) incidence rates (IR) and have distinct staging distributions compared to often advanced stage adenocarcinomas (screeni
Autor:
Anjali Parekh, Camille J. Hochheimer, Jeannine M. Espinoza, Jordan J. Karlitz, Carmen L. Lewis, Sachin Wani, Swati G. Patel
Publikováno v:
Journal of Cancer Prevention
Colorectal cancer (CRC) incidence and mortality are rising in individuals under age 50, termed early age onset (EAO) CRC. Lower endoscopy is recommended for all patients with unexplained iron deficiency anemia (IDA) or hematochezia to assess the EAO-
Autor:
A. Mark Fendrick, Vahab Vahdat, Jing Voon Chen, David Lieberman, Jordan J. Karlitz, Paul J. Limburg, A. Burak Ozbay, John B. Kisiel
10529 Background: The Centers for Medicare & Medicaid Services (CMS) recommends covering blood-based biomarker tests with proposed minimum performance thresholds for colorectal cancer (CRC) screening test every 3 years for average-risk, asymptomatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a94c1729ac3e12d1721cd58d717919
https://doi.org/10.1101/2022.10.27.22281611
https://doi.org/10.1101/2022.10.27.22281611
Publikováno v:
Clinical Gastroenterology and Hepatology.
Autor:
Michelle K. Kim, Meijiao Zhou, Rebecca L. Siegel, Lauren Maniscalco, Steven H. Itzkowitz, Xiao-Cheng Wu, Wesal H. Abualkhair, Jordan J. Karlitz, Eric M. Montminy
Publikováno v:
Annals of Internal Medicine. 174:157-166
BACKGROUND Early-onset colorectal cancer (EOCRC) incidence rates (IRs) are rising, according to previous cancer registry analyses. However, analysis of histologic subtypes, including adenocarcinoma (the focus of CRC screening and diagnostic testing)
Autor:
Carmen L. Lewis, Swati G. Patel, Jeannine M. Espinoza, Viridiana Estrada, Timothy Yen, Sachin Wani, Camille J. Hochheimer, Eric M. Montminy, Jack Scolaro, Wyatt Tarter, Jordan J. Karlitz, Frank I. Scott
Publikováno v:
Clinical Gastroenterology and Hepatology. 21:827-829.e3
The incidence of early onset colorectal cancer, or colorectal cancer (CRC) diagnosed before age 50, is increasing.
Autor:
Christina P, Wang, Jenny J, Lin, Shailja C, Shah, Michelle Kang, Kim, Eric M, Montminy, Sheila D, Rustgi, Jordan J, Karlitz, Steven H, Itzkowitz
Publikováno v:
Clinical Gastroenterology and Hepatology. 21:543-545.e3
Among Asian Americans, cancer is the leading cause of death and colorectal cancer (CRC) is the second most common cancer.
Publikováno v:
Medical Clinics of North America. 104:1023-1036
Colorectal cancer screening is essential to detect and remove premalignant lesions to prevent the development of colorectal cancer. Multiple screening modalities are available, including colonoscopy and stool-based testing. Colonoscopy remains the go